Skip To Main Content
E. Healey on Muck Rack

E. Healey

As seen in: Color Research & Application, Annals of Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to E. Healey’s profile

Articles by E. Healey

The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocol - Healey - 2017 - Musculoskeletal Care - Wiley Online Library

|
By E. Healey, N. Foster, J. L. Proctor, M. H. Lewis, S. Dent, E. m. Hay, C. Jinks, C. A. Chew-Graham, T. Pincus, L. Hartshorne, K. Cooke, E. Nicholls, S. Wathall, J. McBeth
| Color Research & Application Verified
The iPOPP study is an individually randomized, multicentre, three-parallel-arm pilot RCT. A total of 150 participants aged ?65 years with chronic pain in one or more index sites will be recruited and randomized using random permuted blocks, stratified by general practice, to: (i) usual care plus written information; (ii) pedometer plus usual care and written information; or (iii) the iPOPP intervention.
Open in Who Shared Issue with article?

The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocol - Healey - 2018 - Musculoskeletal Care - Wiley Online Library

|
By E. Healey, C. Jinks, N. Foster, C. A. Chew‐Graham
| Arthritis & Rheumatology Verified
The iPOPP study is an individually randomized, multicentre, three‐parallel‐arm pilot RCT. A total of 150 participants aged ≥65 years with chronic pain in one or more index sites will be recruited and randomized using random permuted blocks, stratified by general practice, to: (i) usual care plus written information; (ii) pedometer plus usual care and written information; or (iii) the iPOPP intervention.
Open in Who Shared Issue with article?

Adjuvant chemotherapy for stage III colorectal cancer in the elderly

|
By J. D. Rose, D. Brungs, E. Healey, T. Tubaro
| Annals of Oncology Verified
Background: Colorectal cancer (CRC) is a common and lethal malignancy which is related to aging, with almost 40% of CRC diagnosed above 75 years in both Australia and the United States. Adjuvant chemotherapy is a key treatment in patients with Stage III colorectal cancer, and combination chemotherapy using a fluoropyrimidine and oxaliplatin doublet (such as FOLFOX or XELOX) is the current standard of care, with a 20% reduction in risk of death compared to fluoropyrimidine monotherapy. It is not …
Open in Who Shared Issue with article?
Show More